Literature DB >> 20119555

Operative anesthesia and pain control.

Jeffrey N Winacoo1, Justin A Maykel.   

Abstract

A comprehensive understanding of operative anesthesia and postoperative pain control is essential to the practicing colon and rectal surgeon. Most of the operations performed-particularly in the perineum-cause significant patient discomfort and often result in a lengthy recovery period. A variety of factors, including patient positioning in the operating room and patient expectations, influence the choice of operative anesthesia. Postoperatively numerous modalities and agents exist for pain control. With this variety of options at hand, surgeons should be educated and decisions should be individualized, with the ultimate goals of improving the patient experience and facilitating recovery.

Entities:  

Keywords:  Patient controlled analgesia (PCA); epidural; opioids

Year:  2009        PMID: 20119555      PMCID: PMC2780232          DOI: 10.1055/s-0029-1202885

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  36 in total

1.  Preemptive pain control in patients having laparoscopic hernia repair: a comparison of ketorolac and ibuprofen.

Authors:  C G Mixter; L D Meeker; T J Gavin
Journal:  Arch Surg       Date:  1998-04

2.  Patient-controlled epidural analgesia with bupivacaine and fentanyl on hospital wards: prospective experience with 1,030 surgical patients.

Authors:  S S Liu; H W Allen; G L Olsson
Journal:  Anesthesiology       Date:  1998-03       Impact factor: 7.892

Review 3.  Monitoring opioids.

Authors:  M F Mulroy
Journal:  Reg Anesth       Date:  1996 Nov-Dec

4.  Respiratory-related critical events with intravenous patient-controlled analgesia.

Authors:  M A Ashburn; G Love; N L Pace
Journal:  Clin J Pain       Date:  1994-03       Impact factor: 3.442

5.  A randomized, double-blinded trial of preemptive analgesia in laparoscopy.

Authors:  R W Ke; S G Portera; W Bagous; S R Lincoln
Journal:  Obstet Gynecol       Date:  1998-12       Impact factor: 7.661

6.  Postoperative epidural bupivacaine-morphine therapy. Experience with 4,227 surgical cancer patients.

Authors:  O A de Leon-Casasola; B Parker; M J Lema; P Harrison; J Massey
Journal:  Anesthesiology       Date:  1994-08       Impact factor: 7.892

7.  Dose-response pharmacology of intrathecal morphine in human volunteers.

Authors:  P L Bailey; S Rhondeau; P G Schafer; J K Lu; B S Timmins; W Foster; N L Pace; T H Stanley
Journal:  Anesthesiology       Date:  1993-07       Impact factor: 7.892

8.  Effects of perioperative analgesic technique on rate of recovery after colon surgery.

Authors:  S S Liu; R L Carpenter; D C Mackey; R C Thirlby; S M Rupp; T S Shine; N G Feinglass; P P Metzger; J T Fulmer; S L Smith
Journal:  Anesthesiology       Date:  1995-10       Impact factor: 7.892

9.  Safety assessment of postoperative pain management by an acute pain service.

Authors:  Stphan A Schug; Jane J Torrie
Journal:  Pain       Date:  1993-12       Impact factor: 6.961

10.  Epidural fentanyl, adrenaline and clonidine as adjuvants to local anaesthetics for surgical analgesia: meta-analyses of analgesia and side-effects.

Authors:  M Curatolo; S Petersen-Felix; P Scaramozzino; A M Zbinden
Journal:  Acta Anaesthesiol Scand       Date:  1998-09       Impact factor: 2.105

View more
  2 in total

1.  Evaluation the efficacy of prophylactic tamsulosin in preventing acute urinary retention and other obstructive urinary symptoms following colporrhaphy surgery.

Authors:  Maryam Shokrpour; Elmira Shakiba; Ali Sirous; Alireza Kamali
Journal:  J Family Med Prim Care       Date:  2019-02

Review 2.  A Systematic Review and Meta-Analysis of Intraperitoneal Bupivacaine in Laparoscopic Gynecologic Surgery.

Authors:  Greg Marchand; Kelly Ware; Malini Govindan; Ahmed T Masoud; Alexa King; Stacy Ruther; Giovanna Brazil; Kaitlynne Cieminski; Nicolas Calteux; Catherine Coriell; Hollie Ulibarri; Julia Parise; Amanda Arroyo; Diana Chen; Maria Pierson; Rasa Rafie; Katelyn Sainz
Journal:  J Pain Res       Date:  2021-09-02       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.